Health Care

Brokerage Opinion about two Stocks: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), Agenus Inc. (NASDAQ:AGEN)

0 55

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) initiated the shares trading at $143.45 and showed positive change of +2.58% while the stock’s final trade was registered at $ 146.36. However, its previous closing price was seen at $142.68. The stock negotiated total number of 1 million shares as compared to 3 months average volume of 631.7 thousand shares.

The stock price demonstrated downbeat change from its 50 day moving average of 145.00 and had been up from its 200 Day Moving Average of 134.67.

Intercept Pharmaceuticals, Inc. (ICPT) reported the pricing of its before reported underwritten public offering of $400 million aggregate principal amount of 3.25% convertible senior notes due 2023 (the notes). Intercept has granted the underwriters an option, exercisable for 30 days, to purchase up to an additional $60 million aggregate principal amount of notes on the same terms and conditions, solely to cover over-allotments. The offering is predictable to close on or about July 6, 2016, subject to customary closing conditions.

The average true range of Intercept Pharmaceuticals, Inc.’s (ICPT) is recorded at 9.16 and the relative strength index of the stock stands 50.31. The stock price is going above to its 52 week low with 63.06% and lagging behind from its 52 week high with -48.65%. Analyst recommendation for this stock stands at 2.10. A look on the firm performance, its monthly performance is -12.70% and a quarterly performance of 9.59%. The stock price is trading downbeat from its 200 days moving average with -0.22% and up from 50 days moving average with 0.78%.

Brokerage Recommendations:

According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. Currently shares have been suggested as “BUY” from “2” brokerage firms and recommended as “Strong Buy” by “0” brokerage firms. 1” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “1.66” brokerage firms. “0” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 0 based on consensus of the brokerage firms issuing ratings.

Shares of Agenus Inc. (NASDAQ:AGEN) climbed +3.95% and ended at $4.21 greater than previous closing price of $4.05. The total 849.14 thousand shares were bought and sold throughout the most recent trading session less than average volume of 1.01 million shares.

Agenus Inc.’s (AGEN) has price-to-cash ratio of 2.46 and price to sale ratio of 13.59. . A look on the firm performance, its monthly performance is -6.44% and a quarterly performance of -1.64%. The stock price is moving up from its 20 days moving average with 3.22% and isolated positively from 50 days moving average with 8.93%.

Brokerage Recommendations:

The stock has received ratings from many brokerage firms according to ZACKS. Currently shares have been rated as “Buy” from “0” brokerage firms and “0” brokerage firms say as “Strong Buy”. “0” brokerage firms have suggested “Sell” for the company. “0” brokerage firms have recommended as a “Hold”. Strong Sell rating was given by “1” brokerage firms.  The Company has average brokerage recommendation (ABR) of “0” based on consensus of the ZACKS brokerage firms.

 

 

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter